After consulting on the draft in May, China National Medical Products Administration (NMPA) announced the Administrative Classifications of Medical Sodium Hyaluronate Products with immediate effect on Nov. 14, 2022.1
After consulting on the draft in May, China National Medical Products Administration (NMPA) announced the Administrative Classifications of Medical Sodium Hyaluronate Products with immediate effect on Nov. 14, 2022.1